Tiffany Garbutt, PhD
Tiffany earned her PhD in Genetics from North Carolina State University, where she explored the effect of genetic background on the ability to derive induced pluripotent stem cells. She completed her postdoctoral training at the University of North Carolina at Chapel Hill, specializing in the development of translational approaches to direct cardiac reprogramming and understanding the mechanisms of cardiomyocyte maturation. She has written for multiple medical, nonprofit, and academic peer-reviewed outlets. In March 2020, Tiffany joined LabX Media Group as an assistant science editor for The Scientist. She began working with Drug Discovery News in October 2020.
Articles by Tiffany Garbutt, PhD
| 1 min read
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation.
| 2 min read
Detecting tumor antigens is key to developing effective cancer diagnostics, immunotherapies, and vaccines.
Biobanking gives scientists access to thousands of biological samples, moving
precision medicine one step closer to reality.
| 1 min read
After decades of combating daily assaults, the immune system undergoes dramatic changes that drastically affect human health.
After decades of combating daily assaults, the immune system undergoes dramatic changes that drastically affect human health.
| 1 min read
In the 1930s, HPV
wasn’t on the radar for most scientists.Four decades passed before anyone connected
HPV with cervical, penile, or anal cancer, and it took even longer before scientists
developed a prophylactic vaccine.
Many of the same therapies used to activate the immune system against cancer may also combat infectious diseases.
The blood-brain barrier seems impenetrable, but new therapeutic antibodies may creep past its defenses.
Some infectious diseases require unique modifications to the traditional vaccine development approach.
| 10+ min read
Researchers and patients developed unexpected and innovative solutions to a mysterious disease that appears as little more than a hiccup.
Scientists fight against cancer progression using checkpoint inhibitor drugs.
Available on Demand
Scientists uncover long overlooked players in the gut microbiota and their roles in disease pathogenesis.
Plants offer several unique advantages for accelerated vaccine production.
Amongst a plethora of stem cells, which cell type should scientists choose?
| 4 min read
Scientists and clinicians discussed their solutions for overcoming the challenge of getting past the blood-brain barrier in DDN’s first seminar.
Page 1 of 2 - 29 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Reliable fluid biomarkers strategies for clinical neuroscience research
Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Understanding drug impurities: types, sources, and analytical strategies
Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Discovering cutting-edge nitrosamine analysis in pharmaceuticals
New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
